GGrantIndex
← Leaderboards

Gwen Lomberk

Medical College Of Wisconsin

$4,942,693
Attributed
$6,002,755
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,002,755 · 3

By mechanism

R01$6,002,755 · 3

Top collaborators

Most similar at Medical College Of Wisconsin

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasm Of Pancreas

Research focus

Malignant Neoplasm Of PancreasGeneticInvestigationTumorPathway InteractionsGrowthCell GrowthPharmaceutical PreparationsPreventCellsMolecularPainComplexSignal TransductionPublic Health RelevanceEventEpigenomicsMediatingEpigenetic ProcessGene ExpressionLinkCell CycleFunctional DisorderIn Vivo

Grant awards (17)

Targeting Epigenomic Regulators at the Replication Fork in PDAC$460,768
R01 · FY2025 · CA · contact PI
Targeting Epigenomic Regulators at the Replication Fork in PDAC$434,301
R01 · FY2024 · CA · contact PI
Epigenomic Regulation in Pancreatic Cell Growth$470,535
R01 · FY2023 · DK
Targeting Epigenomic Regulators at the Replication Fork in PDAC$444,584
R01 · FY2023 · CA · contact PI
Epigenomic Regulation in Pancreatic Cell Growth$36,400
R01 · FY2023 · DK
Epigenomic Regulation in Pancreatic Cell Growth$474,144
R01 · FY2022 · DK
Targeting Epigenomic Regulators at the Replication Fork in PDAC$441,252
R01 · FY2022 · CA · contact PI
Epigenomic Regulation in Pancreatic Cell Growth$109,197
R01 · FY2022 · DK
Epigenomic Regulation in Pancreatic Cell Growth$487,218
R01 · FY2021 · DK
Targeting Epigenomic Regulators at the Replication Fork in PDAC$472,850
R01 · FY2021 · CA · contact PI
Epigenomic Regulation in Pancreatic Cell Growth$72,797
R01 · FY2021 · DK
Epigenomic Regulation in Pancreatic Cell Growth$469,834
R01 · FY2020 · DK
Novel Experimental Therapeutics for Pancreatic Cancer$319,550
R01 · FY2018 · CA · contact PI
Novel Experimental Therapeutics for Pancreatic Cancer$319,550
R01 · FY2017 · CA · contact PI
Novel Experimental Therapeutics for Pancreatic Cancer$329,925
R01 · FY2016 · CA · contact PI
Novel Experimental Therapeutics for Pancreatic Cancer$329,925
R01 · FY2015 · CA · contact PI
Novel Experimental Therapeutics for Pancreatic Cancer$329,925
R01 · FY2014 · CA · contact PI